ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 217 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $39,046,000 | -60.8% | 1,400 | -51.7% | 0.01% | -57.9% |
| Q1 2017 | $99,702,000 | -81.3% | 2,900 | -84.3% | 0.02% | -81.6% |
| Q4 2016 | $533,540,000 | -11.7% | 18,500 | -2.6% | 0.10% | -2.8% |
| Q3 2016 | $604,390,000 | -0.4% | 19,000 | +1.6% | 0.11% | 0.0% |
| Q2 2016 | $607,002,000 | -19.9% | 18,700 | -31.0% | 0.11% | -24.8% |
| Q1 2016 | $757,716,000 | -21.6% | 27,100 | 0.0% | 0.14% | -15.1% |
| Q4 2015 | $966,115,000 | -59.0% | 27,100 | -62.0% | 0.17% | -46.3% |
| Q3 2015 | $2,357,891,000 | +64.6% | 71,300 | +108.5% | 0.31% | +94.3% |
| Q2 2015 | $1,432,296,000 | +28.5% | 34,200 | 0.0% | 0.16% | +28.2% |
| Q1 2015 | $1,114,578,000 | – | 34,200 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |